tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
Sanofi SA (SNY)
:SNY
US Market
SNY
Sanofi
Overview
Analyst Forecasts
News & Insights
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Sanofi (SNY) Stock News & Sentiment

Compare
1,936 Followers
Sanofi’s Dupixent Achieves FDA Priority Review for Bullous Pemphigoid Treatment
Premium
Company Announcements
Sanofi’s Dupixent Achieves FDA Priority Review for Bullous Pemphigoid Treatment
1d ago
6K
SNY
Sanofi Ends E.coli Vaccine Trial Amid Efficacy Concerns
Premium
Company Announcements
Sanofi Ends E.coli Vaccine Trial Amid Efficacy Concerns
8d ago
6K
SNY
Sanofi Launches €5 Billion Share Buyback Program
Premium
Company Announcements
Sanofi Launches €5 Billion Share Buyback Program
15d ago
6K
SNY
Sanofi: Strong Market Position and Growth Potential Justify Buy Rating
Premium
Ratings
Sanofi: Strong Market Position and Growth Potential Justify Buy Rating
16d ago
SNY
Sanofi Advances with New Approvals and Strategic Moves in 2025
Premium
Company Announcements
Sanofi Advances with New Approvals and Strategic Moves in 2025
18d ago
6K
SNY
Sanofi’s Earnings Call Highlights Robust Growth and Strategic Focus
Premium
Company Announcements
Sanofi’s Earnings Call Highlights Robust Growth and Strategic Focus
21d ago
SNY
Sanofi Reports Strong Q4 Sales Growth and Promising 2025 Outlook
Premium
Company Announcements
Sanofi Reports Strong Q4 Sales Growth and Promising 2025 Outlook
22d ago
SNY
More SNY News >

SNY News on the Web

Sanofi’s Dupixent Achieves FDA Priority Review for Bullous Pemphigoid Treatment
TipRanks News
Neutral
AstraZeneca Rises Almost 9% in a Month: How to Play the Stock
Zacks
Neutral
BioMarin Q4 Earnings & Sales Top Estimates, Stock Up on Upbeat '25 View
Zacks
Neutral
Sanofi moves closer to selling controlling stake in $17bn-valued Opella
Pharmaceutical Technology
Neutral
Novavax to Report Q4 Earnings: Here's What You Can Expect
Zacks
Neutral
Challenges mount for vaccine makers
Pharma Voice
Neutral
Sanofi Signs Share Purchase Deal To Sell 50% Controlling Stake In Opella To CD&R
rttnews
Neutral
Press Release: Sanofi and CD&R sign Opella share purchase agreement
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
SNY
Sector Average
Media Buzz
This Week14 articles
Weekly Average14.25 articles
News Sentiment
This Week59%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SNY’s Media Buzz Sentiment?
14 articles about SNY were published this week. In an average week, 14.25 articles are published.
    What is SNY’s weekly average amount of articles?
    In an average week, 14.25 articles about SNY are published.
      What is SNY’s News Sentiment?
      59% of articles about SNY were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        RCUSArcus Biosciences
        SHGSingular Health Group Ltd
        HCMHUTCHMED
        PENPenumbra
        AMNAMN Healthcare Services
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing